Caption
: Recruiting trial
= 
; Ongoing trial
= 
-
- GERMANY
- Baden-Württemberg
- HEIDELBERG
- SELICA II: Open, prospective, uncontrolled, multicentre study to evaluate the safety and efficacy of multiple applications of liver cell suspension into the portal vein in newborns with Urea Cycle Disorders (UCDs) (Phase II)
- Universitätsklinikum Heidelberg
- Klinik für Kinderheilkunde I - Sektion für Angeborene Stoffwechselkrankheiten
- More details
